Rating History for Optinose (OPTN) by Piper Sandler

More Stocks Rated by Piper Sandler | Latest Ratings for OPTN
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
3/20/2025 David Amsellem Downgrade Neutral
(Overweight)		 9.00
(15.00)		 6.00
(9.60)		 60% Details